| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |